Becton, Dickinson and Company (BD) stands out in the healthcare industry due to its extensive expertise in medical technology and life sciences. One of BD's key strengths is its robust research and development capabilities, enabling it to innovate constantly in products. Furthermore, BD benefits from a wide-ranging global distribution network that allows for effective market penetration and broad customer access. The company's strong brand reputation and commitment to quality enhance its competitive edge, making it a trusted partner for healthcare providers.
Becton Dickinson And Company - Company Profile
All the data and insights you need on Becton Dickinson And Company in one report.
- • Save hours of research time and resources with our up-to-date Becton Dickinson And Company Strategy Report
- • Understand Becton Dickinson And Company's position in the market, performance, and strategic initiatives
- • Gain competitive edge and increase your chances of success
Becton Dickinson And Company Competitors
| Competitor | Headquarters | No. of Employees | Revenue | Entity Type |
|---|---|---|---|---|
Thermo Fisher Scientific | United States of America | 80,000+ | $40.3B | Public |
Siemens Healthineers | Germany | 50,000+ | $19.5B | Public |
Abbott Laboratories | United States of America | 113,000 | $43.6B | Public |
Johnson & Johnson | United States of America | 132,200 | $93.8B | Public |
Roche Diagnostics | Switzerland | 94,000 | $61.5B | Public |
Medtronic | Ireland | 90,000+ | $30.2B | Public |
Stryker Corporation | United States of America | 40,000+ | $17.0B | Public |
Baxter International | United States of America | 60,000 | $13.8B | Public |
PerkinElmer | United States of America | 14,000+ | $4.0B | Public |
Danaher Corporation | United States of America | 78,000 | $31.5B | Public |
GE Healthcare | United States of America | 50,000+ | $19.3B | Public |
Bio-Rad Laboratories | United States of America | 8,700+ | $2.6B | Public |
Charles River Laboratories | United States of America | 18,000+ | $3.1B | Public |
Illumina | United States of America | 7,600+ | $4.1B | Public |
RMD Networks | United States of America | 200+ | $0.05B | Private |
Overview of Becton Dickinson And Company's competitor analysis
Becton, Dickinson and Company operates in a competitive landscape filled with numerous well-established players in the medical technology and diagnostic industries. Major competitors include Thermo Fisher Scientific, Abbott Laboratories, and Johnson & Johnson, all of which are significant entities with extensive resources and experience. Each competitor has distinct market positions, leveraging advancements in technology and broad product portfolios to maintain competitive advantages. The overall industry is characterized by rapid innovation, strategic mergers, and a focus on improving healthcare delivery worldwide, making competition intense and dynamic.
What are Becton Dickinson And Company's key strengths compared to competitors?
FAQs
Who are the main competitors of Becton-Dickinson-and-Company?
Becton, Dickinson and Company (BD) faces competition from several major firms in the healthcare and medical technology sector. Notable competitors include Abbott Laboratories, Thermo Fisher Scientific, Medtronic, and Siemens Healthineers. Each of these companies poses significant competition with their respective product lines and innovations in diagnostics and medical devices.
Which company is the largest competitor of Becton-Dickinson-and-Company in terms of revenue?
The largest competitor of Becton, Dickinson and Company (BD) is Thermo Fisher Scientific, with an impressive revenue of approximately $35 billion in the last fiscal year. This positions Thermo Fisher ahead of BD, which reported revenues nearing $17 billion. This substantial difference signifies Thermo Fisher's broad market impact and strong business strategies.
What are Becton-Dickinson-and-Company’s key strengths compared to competitors?
Becton, Dickinson and Company (BD) showcases significant strengths that elevate its position in the marketplace. The company has a highly efficient supply chain management and retains cutting-edge technological advancements in its product offerings. Additionally, BD maintains strong partnerships within the healthcare sector, facilitating access to a diverse array of clients and ensuring its products meet the highest standards of quality and efficacy.
Where can I find a detailed comparison of Becton-Dickinson-and-Company and its competitors?
Thermo Fisher Scientific
Headquarters:
United States of America
No. of Employees:
80,000+
Revenue:
$40.3B
Entity Type:
Public
Siemens Healthineers
Headquarters:
Germany
No. of Employees:
50,000+
Revenue:
$19.5B
Entity Type:
Public
Abbott Laboratories
Headquarters:
United States of America
No. of Employees:
113,000
Revenue:
$43.6B
Entity Type:
Public
Johnson & Johnson
Headquarters:
United States of America
No. of Employees:
132,200
Revenue:
$93.8B
Entity Type:
Public
Roche Diagnostics
Headquarters:
Switzerland
No. of Employees:
94,000
Revenue:
$61.5B
Entity Type:
Public
Medtronic
Headquarters:
Ireland
No. of Employees:
90,000+
Revenue:
$30.2B
Entity Type:
Public
Stryker Corporation
Headquarters:
United States of America
No. of Employees:
40,000+
Revenue:
$17.0B
Entity Type:
Public
Baxter International
Headquarters:
United States of America
No. of Employees:
60,000
Revenue:
$13.8B
Entity Type:
Public
PerkinElmer
Headquarters:
United States of America
No. of Employees:
14,000+
Revenue:
$4.0B
Entity Type:
Public
Danaher Corporation
Headquarters:
United States of America
No. of Employees:
78,000
Revenue:
$31.5B
Entity Type:
Public
GE Healthcare
Headquarters:
United States of America
No. of Employees:
50,000+
Revenue:
$19.3B
Entity Type:
Public
Bio-Rad Laboratories
Headquarters:
United States of America
No. of Employees:
8,700+
Revenue:
$2.6B
Entity Type:
Public
Charles River Laboratories
Headquarters:
United States of America
No. of Employees:
18,000+
Revenue:
$3.1B
Entity Type:
Public
Illumina
Headquarters:
United States of America
No. of Employees:
7,600+
Revenue:
$4.1B
Entity Type:
Public
RMD Networks
Headquarters:
United States of America
No. of Employees:
200+
Revenue:
$0.05B
Entity Type:
Private
Overview of Becton Dickinson And Company competitor analysis
Becton, Dickinson and Company operates in a competitive landscape filled with numerous well-established players in the medical technology and diagnostic industries. Major competitors include Thermo Fisher Scientific, Abbott Laboratories, and Johnson & Johnson, all of which are significant entities with extensive resources and experience. Each competitor has distinct market positions, leveraging advancements in technology and broad product portfolios to maintain competitive advantages. The overall industry is characterized by rapid innovation, strategic mergers, and a focus on improving healthcare delivery worldwide, making competition intense and dynamic.